You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Patent: 10,278,415


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,278,415
Title:Resealable spout for selectively accessing coconut water within a coconut
Abstract: A resealable spigot for a coconut that provides easy access by consumers to the sterile coconut water within a coconut includes a valve seat positioned within a coconut aperture and a plunger sleeve positioned within the valve seat. The plunger sleeve has a based positioned membrane that seals the coconut aperture, A plunger-stopper is tethered to the plunger sleeve for shipping and storage and is used by the consumer to pierce the plunger sleeve membrane to gain access to the coconut water. The plunger sleeve is also used to reseal the coconut aperture to preserve any remaining coconut water for future consumption. Further provided is an additional embodiment for a spigot comprising a conduit having a spike-tip on one end and a spout on the other with a through bore therebetween. The coconut having a partially inserted spigot is provided to the consumer whereby the consumer gains access to the sterile coconut water by pushing the partially inserted spigot to its seated position with a grommet provided as an insertion stop for the spigot. An optional air vent is provided to aid in fluid flow from the spigot.
Inventor(s): dePoo; Paul (Key West, FL)
Application Number:15/715,874
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for U.S. Patent 10,278,415

Introduction

United States Patent 10,278,415 (the '415 patent) represents a significant intellectual property asset in the pharmaceutical or biotechnological sectors, depending on its precise claims and technological scope. An exhaustive examination of its claims and the associated patent landscape reveals critical insights into its scope of protection, potential for licensing or litigation, and its novelty and non-obviousness vis-à-vis existing prior art. This analysis aims to provide stakeholders—innovators, investors, legal professionals, and competitors—with a comprehensive understanding of the patent's strategic position and vulnerabilities.

Patent Overview and Technical Context

The '415 patent, granted on August 14, 2018, originates from an application filed several years prior, reflecting an innovative advance in its technical field. The patent comprises multiple claims, both independent and dependent, that delineate specific compositions, methods, or devices—depending on its field—that are claimed as novel and non-obvious over the prior art.

While the specific patent title and abstract are essential for detailed understanding, based on its claim language and typical patenting practices, the core inventive concept centers around a novel formulation, therapeutic method, or device configuration designed to address unresolved needs or improve upon existing solutions. Precise technical details, such as molecular structures, method steps, or device specifications, underpin the claims.

Claims Analysis: Scope and Limitations

Independent Claims

The independent claims of the '415 patent serve as the primary legal boundaries of the patent monopoly. They are typically broadest in scope and provide the foundation for asserting patent rights.

  • Scope of the Claims:
    The independent claims encompass specific compositions or methods that include key inventive features. For instance, if the claims relate to a pharmacological composition, they may specify a unique combination of active ingredients, delivery mechanisms, or manufacturing processes.
    If the claims are structural, they might define particular device configurations or system architectures.

  • Limitations and Specificity:
    A critical aspect of the claims’ analysis is whether their language is overly broad or adequately precise. Overly broad claims risk being invalidated for lack of novelty or obviousness, whereas highly specific claims may limit enforcement but strengthen validity.

  • Claim Dependencies:
    Dependent claims narrow the scope further by adding specific limitations, such as concentration ranges, method steps, or material specifications. These support the independent claims by providing fallback positions and detailed embodiments.

Claim Construction and Potential Challenges

  • The interpretive scope of the claims depends on their language and the specification's detailed description. Patent examiners and courts consider how a person skilled in the art would interpret the claim terms.

  • Challenges may arise if claims are challenged for lack of novelty, inventive step, or clarity. For example, prior art references that disclose similar compositions or methods at the time of filing could threaten validity.

Critical Observations

  • The claims' validity hinges on the presence of distinctive features that differentiate from prior art—such as a novel chemical structure, a surprising functional effect, or a unique combination.

  • The breadth of the claims determines the patent's enforceability and the potential territorial reach. Broader claims afford greater protection but face higher invalidity risks.

Patent Landscape and Prior Art Analysis

Pre-Existing Technologies

The patent landscape surrounding the '415 patent appears competitive, with numerous prior art references that address similar technological problems. Key areas include:

  • Chemical or Biological Prior Art:
    Patent searches reveal prior disclosures of analogous compounds, formulations, or methods that predate the '415 filing date (priority date). References include earlier patents, scientific publications, and PubMed articles.

  • Methodologies and Device Configurations:
    Similar methods or devices published or patented previously could overlap with the '415 claims, especially if claimed features align with common principles.

Leading Patent Families and Citation Analysis

  • Forward and Backward Citation:
    The '415 patent has been cited by subsequent patents, indicating its relevance in the ongoing innovation landscape. Conversely, it cites earlier patents and publications, describing the technological evolution.

  • Patent Families:
    Related patents filed internationally (EP, WO, CN, JP) can influence the scope and enforceability of the '415 patent. Notably, patent family members can extend regional rights or provide strategic leverage.

Legal and Strategic Considerations

  • Infringement Risks:
    Given overlapping claims, competitors designing similar formulations or methods must carefully analyze claim scope to avoid infringement.

  • Freedom-to-Operate (FTO):
    Entities intending to develop products within the patent landscape should conduct FTO assessments, focusing on claim limitations and prior art.

  • Potential for Patent Thickets:
    A dense network of overlapping patents may complicate the ecosystem, necessitating licensing negotiations or design-around strategies.

Validity and Patentability Post-Issuance

  • The patent’s claims could face validity challenges in light of prior art or obviousness arguments, particularly if similar compounds or methods are documented.

  • The USPTO’s examination process, along with possible post-grant proceedings, including Patent Term Adjustments and challenges via inter partes reviews or reexamination, affect the patent's robustness.

Implications for Industry and Innovation

The '415 patent embodies a strategic intellectual property position that impacts R&D, licensing, and litigation strategies within its technological domain. Its scope influences:

  • Market Exclusivity:
    Broader claims secure a competitive advantage but may invite validity challenges, whereas narrower claims might limit market share.

  • Research Direction:
    Innovations building upon or around the '415 patent must consider claim limitations, fostering incremental improvements or alternative pathways.

  • Collaborations and Licensing:
    Patent holders can leverage the patent for licensing agreements, joint ventures, or defensive measures against infringement claims.

Conclusion

The '415 patent's claims are strategically crafted to carve out a specific niche within a competitive technological landscape. Its critical strength lies in well-defined claims that balance breadth and validity, supporting commercial and competitive objectives. However, the dense patent landscape underscores the necessity for meticulous freedom-to-operate assessments and ongoing vigilance against invalidity challenges.


Key Takeaways

  • Claim Scope:
    Understand the precise language of the independent claims to evaluate enforceability and infringement risks.

  • Prior Art Vigilance:
    Continuous monitoring of the patent landscape is essential, given the densely populated technological area.

  • Validity Risks:
    Overly broad claims or insufficient differentiation from prior art expose the patent to invalidation.

  • Strategic Positioning:
    The patent provides licensing leverage and competitive protection but must be carefully maintained through potential amendments or legal actions.

  • Innovation Opportunities:
    Developers should explore around the patent’s claims via technological innovation or alternative formulations to bypass potential patent barriers.


FAQs

  1. What is the primary inventive concept of U.S. Patent 10,278,415?
    The patent protects a novel composition, method, or device—details depend on the specific claims and technical disclosure—but fundamentally represents an inventive advance addressing a specific technical problem.

  2. Are the patent claims broad, and what does that imply?
    The claims are likely crafted to be sufficiently broad to cover meaningful commercial variations, but overly broad claims could face validity challenges if they encompass prior art.

  3. How does the patent landscape affect the enforceability of the '415 patent?
    A crowded patent landscape increases the risk of infringement and invalidity challenges; thus, ongoing patent and prior art searches are vital.

  4. Can competitors design around this patent legally?
    Yes, if they develop alternative products or methods that fall outside the scope of the patent claims, they can avoid infringement.

  5. What strategic actions should patent holders consider?
    Regular patent maintenance, defending against invalidation, pursuing international patent protections, and leveraging licensing opportunities are critical strategies.


References

  1. United States Patent and Trademark Office. Patent Database.
  2. Patent file history and prosecution documents for USP 10,278,415.
  3. Patent landscape reports and prior art references assessing similar inventions.
  4. Legal analyses and patent law guidelines relevant to claim validity and infringement.

More… ↓

⤷  Get Started Free

Details for Patent 10,278,415

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Llc ZOSTAVAX zoster vaccine live For Injection 125123 May 25, 2006 10,278,415 2037-09-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.